Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.84 USD | -2.41% | -29.00% | -58.69% |
May. 20 | SAB Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 06 | SAB Biotherapeutics, Inc. Appoints Jay Skyler, Md, to the Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.69% | 26.2M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.67% | 21.97B | |
-4.64% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- SABS Stock
- News SAB Biotherapeutics, Inc.
- Chardan Capital Adjusts SAB Biotherapeutics' Price Target to $7 from $10, Keeps Buy Rating